Compare BHVN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | STAA |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2017 | N/A |
| Metric | BHVN | STAA |
|---|---|---|
| Price | $10.76 | $17.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | ★ $30.36 | $23.53 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 03-02-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.48 | $13.50 |
| 52 Week High | $44.28 | $30.81 |
| Indicator | BHVN | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 25.90 |
| Support Level | $10.61 | $16.94 |
| Resistance Level | $12.90 | $19.54 |
| Average True Range (ATR) | 0.80 | 0.78 |
| MACD | -0.23 | -0.11 |
| Stochastic Oscillator | 17.66 | 12.24 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.